공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 임상시험 시장(2021-2027년) : 시장 예측(단계, 시험 설계, 치료 분야별), 산업 동향, 지역적 전망, 용도 잠재성, 가격 동향, 시장 점유율

Clinical Trials Market Size By Phases, By Study Design, By Therapeutic Area, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

리서치사 Global Market Insights Inc.
발행일 2021년 04월 상품 코드 1000736
페이지 정보 영문 150 Pages
가격
US $ 5,150 ₩ 5,909,000 Unprintable PDF (Single User License)
US $ 7,150 ₩ 8,204,000 Printable PDF (Multi User License)
US $ 9,150 ₩ 10,499,000 Printable PDF (Enterprise User License)


세계의 임상시험 시장(2021-2027년) : 시장 예측(단계, 시험 설계, 치료 분야별), 산업 동향, 지역적 전망, 용도 잠재성, 가격 동향, 시장 점유율 Clinical Trials Market Size By Phases, By Study Design, By Therapeutic Area, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
발행일 : 2021년 04월 페이지 정보 : 영문 150 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 임상시험 시장은 만성질환 증가, FDA에 의한 규제 강화, 다양한 질환에 대한 새로운 치료법 발견을 향한 지속적인 대처 등에 의해 향후 수십 년간 상당한 성장을 나타낼 것으로 예측됩니다.

단계별로는 단계 IV 부문이 2020년에 79억 달러 이상을 나타내고, 예측기간 중에도 빠른 속도로 성장할 것으로 예측됩니다. 또한 시험 설계별로는 개입 연구 부문이 2020년에 77.4%의 시장 점유율을 나타내고 있으며, 향후에도 높은 성장이 전망됩니다. 또한 치료 분야별로는 안과 부문이 2027년 말에 약 39억 달러 규모를 나타낼 것으로 예측됩니다.

세계의 임상시험(Clinical Trials) 시장을 조사했으며, 시장 정의와 개요, 신종 코로나바이러스 감염증(COVID-19) 및 기타 시장 영향요인 분석, 시장 규모 추정과 예측, 단계·시험 설계·치료 분야·지역/주요 국가 등 각종 세분화별 내역, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

제1장 조사 방법

제2장 주요 요약

제3장 산업 분석

  • 산업 분류
  • 산업 상황
  • 산업에 대한 영향요인
    • 성장 촉진요인
    • 잠재적 위험과 과제
  • 성장 가능성
  • COVID-19 : 영향 분석
  • Porter's Five Forces 분석
  • 경쟁 상황
  • PESTEL 분석

제4장 시장 분석과 예측 : 단계별

  • 단계 I
  • 단계 II
  • 단계 III
  • 단계 IV

제5장 시장 분석과 예측 : 시험 설계별

  • 개입 연구
  • 관찰 연구
  • 확대 액세스 연구

제6장 시장 분석과 예측 : 치료 분야별

  • 자가면역질환
  • 종양
  • 심장
  • 감염증
  • 피부과
  • 안과
  • 기타

제7장 시장 분석과 예측 : 지역·주요 국가별

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제8장 기업 개요

  • 경쟁 대시보드
  • Bioclinica
  • ICON plc
  • Laboratory Corporation of American Holding(Covance Inc)
  • Medpace, Inc
  • Pharmaceutical Product Development, LLC(PPD)
  • PRA Health Sciences
  • WuXi AppTec
  • Parexel International Corporation
  • Charles River Laboratories(MPI Research)
  • Apex Medical Research
  • IQVIA
KSM 21.04.28

Data Tables

  • TABLE 1 Global clinical trials market, 2016 - 2020 (USD Million)
  • TABLE 2 Global clinical trials market, 2021 - 2027 (USD Million)
  • TABLE 3 Global clinical trials market, by phases, 2016 - 2020 (USD Million)
  • TABLE 4 Global clinical trials market, by phases, 2021- 2027 (USD Million)
  • TABLE 5 Global clinical trials market, by study design, 2016 - 2020 (USD Million)
  • TABLE 6 Global clinical trials market, by study design, 2021- 2027 (USD Million)
  • TABLE 7 Global clinical trials market, by therapeutic area, 2016 - 2020 (USD Million)
  • TABLE 8 Global clinical trials market, by therapeutic area, 2021- 2027 (USD Million)
  • TABLE 9 Global clinical trials market, by region, 2016 - 2020 (USD Million)
  • TABLE 10 Global clinical trials market, by region, 2021 - 2027 (USD Million)
  • TABLE 11 Industry impact forces
  • TABLE 12 Phase I market size, by region, 2016 - 2020 (USD Million)
  • TABLE 13 Phase I market size, by region, 2021 - 2027 (USD Million)
  • TABLE 14 Phase II market size, by region, 2016 - 2020 (USD Million)
  • TABLE 15 Phase II market size, by region, 2021 - 20207 (USD Million)
  • TABLE 16 Phase III market size, by region, 2016 - 2020 (USD Million)
  • TABLE 17 Phase III market size, by region, 2021 - 2027 (USD Million)
  • TABLE 18 Phase IV market size, by region, 2016 - 2020 (USD Million)
  • TABLE 19 Phase IV market size, by region, 2021 - 2027 (USD Million)
  • TABLE 20 Interventional study market size, by region, 2016 - 2020 (USD Million)
  • TABLE 21 Interventional study market size, by region, 2021 - 2027 (USD Million)
  • TABLE 22 Observational study market size, by region, 2016 - 2020 (USD Million)
  • TABLE 23 Observational study market size, by region, 2021 - 2027 (USD Million)
  • TABLE 24 Expanded access study market size, by region, 2016 - 2020 (USD Million)
  • TABLE 25 Expanded access study market size, by region, 2021 - 2027 (USD Million)
  • TABLE 26 Autoimmune disease market size, by region, 2016 - 2020 (USD Million)
  • TABLE 27 Autoimmune disease market size, by region, 2021 - 2027 (USD Million)
  • TABLE 28 Oncology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 29 Oncology market size, by region, 2021 - 20207 (USD Million)
  • TABLE 30 Cardiology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 31 Cardiology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 32 Infectious disease market size, by region, 2016 - 2020 (USD Million)
  • TABLE 33 Infectious disease market size, by region, 2021 - 2027 (USD Million)
  • TABLE 34 Dermatology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 35 Dermatology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 36 Ophthalmology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 37 Ophthalmology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 38 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 39 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 40 North America clinical trials market size, by country, 2016 - 2020 (USD Million)
  • TABLE 41 North America clinical trials market size, by country, 2021- 2027 (USD Million)
  • TABLE 42 North America clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 43 North America clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 44 North America clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 45 North America clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 46 North America clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 47 North America clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 48 U.S. clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 49 U.S. clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 50 U.S. clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 51 U.S. clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 52 U.S. clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 53 U.S. clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 54 Canada clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 55 Canada clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 56 Canada clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 57 Canada clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 58 Canada clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 59 Canada clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 60 Europe clinical trials market size, by country, 2016 - 2020 (USD Million)
  • TABLE 61 Europe clinical trials market size, by country, 2021- 2027 (USD Million)
  • TABLE 62 Europe clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 63 Europe clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 64 Europe clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 65 Europe clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 66 Europe clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 67 Europe clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 68 Germany clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 69 Germany clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 70 Germany clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 71 Germany clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 72 Germany clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 73 Germany clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 74 UK clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 75 UK clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 76 UK clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 77 UK clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 78 UK clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 79 UK clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 80 France clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 81 France clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 82 France clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 83 France clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 84 France clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 85 France clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 86 Italy clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 87 Italy clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 88 Italy clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 89 Italy clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 90 Italy clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 91 Italy clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 92 Spain clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 93 Spain clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 94 Spain clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 95 Spain clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 96 Spain clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 97 Spain clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 98 Asia Pacific clinical trials market size, by country, 2016 - 2020 (USD Million)
  • TABLE 99 Asia Pacific clinical trials market size, by country, 2021- 2027 (USD Million)
  • TABLE 100 Asia Pacific clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 101 Asia Pacific clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 102 Asia Pacific clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 103 Asia Pacific clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 104 Asia Pacific clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 105 Asia Pacific clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 106 Japan clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 107 Japan clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 108 Japan clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 109 Japan clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 110 Japan clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 111 Japan clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 112 China clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 113 China clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 114 China clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 115 China clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 116 China clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 117 China clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 118 India clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 119 India clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 120 India clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 121 India clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 122 India clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 123 India clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 124 Australia clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 125 Australia clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 126 Australia clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 127 Australia clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 128 Australia clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 129 Australia clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 130 Singapore clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 131 Singapore clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 132 Singapore clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 133 Singapore clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 134 Singapore clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 135 Singapore clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 136 Malaysia clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 137 Malaysia Clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 138 Malaysia clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 139 Malaysia clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 140 Malaysia clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 141 Malaysia clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 142 Indonesia clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 143 Indonesia Clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 144 Indonesia clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 145 Indonesia clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 146 Indonesia clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 147 Indonesia clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 148 Thailand clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 149 Thailand Clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 150 Thailand clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 151 Thailand clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 152 Thailand clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 153 Thailand clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 154 South Korea clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 155 South Korea Clinical Trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 156 South Korea clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 157 South Korea clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 158 South Korea clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 159 South Korea clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 160 Philippines clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 161 Philippines Clinical Trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 162 Philippines clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 163 Philippines clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 164 Philippines clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 165 Philippines clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 166 Latin America clinical trials market size, by country, 2016 - 2020 (USD Million)
  • TABLE 167 Latin America clinical trials market size, by country, 2021- 2027 (USD Million)
  • TABLE 168 Latin America clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 169 Latin America clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 170 Latin America clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 171 Latin America clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 172 Latin America clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 173 Latin America clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 174 Brazil clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 175 Brazil Clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 176 Brazil clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 177 Brazil clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 178 Brazil clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 179 Brazil clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 180 Mexico clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 181 Mexico Clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 182 Mexico clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 183 Mexico clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 184 Mexico clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 185 Mexico clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 186 MEA clinical trials market size, by country, 2016 - 2020 (USD Million)
  • TABLE 187 MEA clinical trials market size, by country, 2021- 2027 (USD Million)
  • TABLE 188 MEA clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 189 MEA clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 190 MEA clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 191 MEA clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 192 MEA clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 193 MEA clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 194 South Africa clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 195 South Africa Clinical Trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 196 South Africa clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 197 South Africa clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 198 South Africa clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 199 South Africa clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 200 Saudi Arabia clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 201 Saudi Arabia Clinical Trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 202 Saudi Arabia clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 203 Saudi Arabia clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 204 Saudi Arabia clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 205 Saudi Arabia clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Clinical trials industry, 360 degree synopsis, 2016-2027
  • FIG. 4 Industry segmentation
  • FIG. 5 Global clinical trials market, 2016 - 2027 (USD Million)
  • FIG. 6 Growth potential analysis, by phases
  • FIG. 7 Growth potential analysis, by study design
  • FIG. 8 Growth potential analysis, by therapeutic area
  • FIG. 9 Porter's analysis
  • FIG. 10 Company matrix analysis, 2020
  • FIG. 11 PESTEL analysis
  • FIG. 12 Key segment trends, by phases
  • FIG. 13 Key segment trends, by study design
  • FIG. 14 Key segment trends, by therapeutic area
  • FIG. 15 Key regional trends
  • FIG. 16 Competitive dashboard, 2020

The clinical trials market is projected to gain massive momentum in the decades to come owing to rising prevalence of chronic diseases, growing FDA regulations, and ongoing efforts towards discovering new treatments for various diseases. Clinical trials are a kind of research that thoroughly studies novel tests as well as treatments to evaluate their effects on the human health results.

These studies are usually performed to find more better ways to stop, screen for, treat or diagnose a disease. These trials might also exhibit which medical approaches might work best for certain group of people or illnesses. Clinical trials are also known to produce top-quality data for healthcare decision making.

The clinical trials market is segmented in terms of phases, study design, therapeutic area, and regional landscape.

Based on phases, the clinical trials market is categorized into phase IV, phase III, phase II, and phases I. In 2020, the phase IV segment accounted for more than $7.9 billion and is anticipated to progress at rapid pace over the projected period. A phase IV trial for medical devices or drugs usually takes place after a regulatory health authority, like the U.S. FDA (Food and Drug Administration) has given it its approval for use.

The effectiveness as well as safety of a drug or device are monitored in typically large, diverse populations. At times, the side effects of a drug might not become clear until and unless more individuals have taken it over a longer time period.

With respect to study design, the market for clinical trials is classified into expanded access study, observational study, and interventional study. Among these, the interventional study segment accounted for a market share of 77.4% in 2020 and will exhibit strong growth coming time.

These studies are often prospective and are particularly tailored to assess direct impacts of treatment or preventive measures on disease. Each of these study design has some specific outcome measures that depend on the type as well as the quality of data utilized.

In terms of therapeutic area, the overall clinical trials market is bifurcated into ophthalmology, dermatology, infectious disease, cardiology, oncology, autoimmune disease, and others. Ophthalmology segment is expected to reach a valuation of approximately $3.9 billion by the end of 2027.

From a regional frame of reference, in 2020, the Latin America clinical trials market accounted a market share of more than 3.8% and will exhibit a promising growth rate during the study period.

Meanwhile, Middle East & Africa is anticipated to show steady growth of 6.7% during the analysis time period.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data Sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Clinical trials industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Phases trends
    • 2.1.3 Study design
    • 2.1.4 Therapeutic area trends
    • 2.1.5 Regional trends

Chapter 3 Clinical Trials Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rise in government funding for clinical trials
      • 3.3.1.2 Growing demand for outsourcing clinical trials to CROs
      • 3.3.1.3 Increasing R&D expenditure
      • 3.3.1.4 Opportunities for conducting clinical trials in Asian countries
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Regulatory complications in Asia Pacific region
      • 3.3.2.2 Infrastructural barriers in developing countries
  • 3.4 Growth potential analysis
    • 3.4.1 By phases
    • 3.4.2 By study design
    • 3.4.3 By therapeutic area
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2020
    • 3.7.1 Company matrix analysis
  • 3.8 PESTEL analysis

Chapter 4 Clinical Trials Market, By Phase

  • 4.1 Key segment trend
  • 4.2 Phase I
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Phase II
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Phase III
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.5 Phase IV
    • 4.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Clinical Trials Market, By Study Design

  • 5.1 Key segment trend
  • 5.2 Interventional study
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Observational study
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Expanded access study
    • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Clinical Trials Market, By Therapeutic Area

  • 6.1 Key segment trend
  • 6.2 Autoimmune disease
    • 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.3 Oncology
    • 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.4 Cardiology
    • 6.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.5 Infectious disease
    • 6.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.6 Dermatology
    • 6.6.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.7 Ophthalmology
    • 6.7.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.8 Others
    • 6.8.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 7 Clinical Trials Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.2.2 Market size, by phases, 2016 - 2027 (USD Million)
    • 7.2.3 Market size, by study design, 2016 - 2027 (USD Million)
    • 7.2.4 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.2.5.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.2.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.2.6.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.2.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.3.2 Market size, by phases, 2016 - 2027 (USD Million)
    • 7.3.3 Market size, by study design, 2016 - 2027 (USD Million)
    • 7.3.4 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.3.5.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.3.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.3.6.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.3.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.3.7.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.3.7.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.8 Spain
      • 7.3.8.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.3.8.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.3.8.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.9 Italy
      • 7.3.9.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.3.9.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.3.9.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.4.2 Market size, by phases, 2016 - 2027 (USD Million)
    • 7.4.3 Market size, by study design, 2016 - 2027 (USD Million)
    • 7.4.4 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.5.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.6.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.7.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.7.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.8.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.8.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.9.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.9.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.10 Singapore
      • 7.4.10.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.10.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.10.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.11 Malaysia
      • 7.4.11.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.11.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.11.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.12 Indonesia
      • 7.4.12.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.12.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.12.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.13 Thailand
      • 7.4.13.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.13.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.13.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.14 Philippines
      • 7.4.14.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.14.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.14.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.5.2 Market size, by phases, 2016 - 2027 (USD Million)
    • 7.5.3 Market size, by study design, 2016 - 2027 (USD Million)
    • 7.5.4 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.5.5.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.5.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.5.6.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.5.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
  • 7.6 Middle East and Africa
    • 7.6.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.6.2 Market size, by phases, 2016 - 2027 (USD Million)
    • 7.6.3 Market size, by study design, 2016 - 2027 (USD Million)
    • 7.6.4 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.6.5.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.6.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.6.6.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.6.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard
  • 8.2 Bioclinica
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 ICON plc
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Laboratory Corporation of American Holding (Covance Inc)
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Medpace, Inc
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Pharmaceutical Product Development, LLC (PPD)
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 PRA Health Sciences
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 WuXi AppTec
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Parexel International Corporation
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Charles River Laboratories (MPI Research)
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Apex Medical Research
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 IQVIA
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
Back to Top
전화 문의
F A Q